For the first time, doctors said Monday they have found a pill that improves survival for people with liver cancer, a notoriously hard to treat disease diagnosed in more than half a million people globally each year
More than thirty years after President Nixon vowed to win the war on cancer, the battle rages on with no victor in sight. But that won't stop Big Pharma and biotechs alike from trying to entice investors next week with fresh reports on the hunt for a panacea.
The threat to Big Pharma is real - the nation's drugmakers stand to lose nearly seven percent of their sales to drugs going off patent this year - and more CEOs who don't get ahead of the problem could end up losing their jobs.
Sutent, an anti-cancer drug from Pfizer that's been on the market just a few months, shrank tumors and stopped them from spreading in the lungs and kidneys of patients, according to studies unveiled this weekend.